February 2003

|
Volume 15 Issue 3
ABSTRACT: Goal. To investigate the incidence of early (< 24 hours) and late (> 24 hours to 7 days) reactions to 3 contrast agents commonly used in cardiac catheterization. Methods and Results. A total of 2,108 patients undergoing cardiac cathet…
Superior vena cava syndrome (SVCS) is a distressing manifestation of benign or malignant disease obstructing return of blood flow through the superior vena cava (SVC).1 Patients with this syndrome can be extremely uncomfortable or may develop life-th…
Small intimal dissections occur frequently after percutaneous coronary intervention (PCI), but are usually associated with a benign course. Following balloon angioplasty, coronary dissection is detected by angiography in 20–40% of cases1–3 and by int…
Patent foramen ovale (PFO) is increasingly recognized as a mediator of Patent foramen ovale (PFO) is increasingly recognized as a mediator of paradoxical embolism,1,2 refractory hypoxemia3,4 and platypnea-orthodeoxia syndrome.5–7 Many specialists are…
Introduction. Over the past decade, appreciable reductions in mortality, reinfarction and length of hospital stay have been reported in large-scale trials of patients with acute coronary syndromes (ACS). Every year, approximately 1.5 million patients…
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, case reports, a CME offering, articles from the Journal special sections “Acute Coronary Syndromes” and “Interventional Pediatric Cardiology”, as wel…
Coronary artery disease is common in adult patients with end-stage liver disease who are candidates for orthotopic liver transplantation.1 Patients with end-stage liver disease are predisposed to spontaneous bleeding complications due to thrombocytop…
Acute coronary syndromes (ACS) represent a clinical spectrum that extends all the way from unstable angina presenting with worsening episodes of chest pain, to non-ST segment elevation myocardial infarction (NSTEMI) with more prolonged chest pain and…
The dilemma of invasive versus conservative strategies. After patients with unstable angina and NSTEMI have been stabilized with medical therapy, a decision must be made regarding risk stratification. Several randomized trials have compared outcomes…
The early and mid-term results of the Amplatzer Duct Occluder (ADO) (AGA Medical Corporation, Golden Valley, Minnesota) for obliterating flow through a patent arterial duct are highly encouraging.1,2 High occlusion rates, low complication rates and a…